Ameritas Investment Partners’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $66.4K | Hold |
11,436
| – | – | ﹤0.01% | 2074 |
|
|
2026
Q1 | $82.9K | Buy |
11,436
+2,072
| +22% | +$27K | ﹤0.01% | 1795 |
|
|
2025
Q4 | $159K | Hold |
9,364
| – | – | ﹤0.01% | 1395 |
|
|
2025
Q3 | $68.5K | Sell |
9,364
-2,080
| -18% | -$16.8K | ﹤0.01% | 1920 |
|
|
2025
Q2 | $74.4K | Buy |
11,444
+1,802
| +19% | +$11.9K | ﹤0.01% | 1934 |
|
|
2025
Q1 | $77.9K | Hold |
9,642
| – | – | ﹤0.01% | 1864 |
|
|
2024
Q4 | $119K | Buy |
9,642
+2,308
| +31% | +$30.8K | ﹤0.01% | 1653 |
|
|
2024
Q3 | $60.1K | Hold |
7,334
| – | – | ﹤0.01% | 2082 |
|
|
2024
Q2 | $36.6K | Hold |
7,334
| – | – | ﹤0.01% | 2309 |
|
|
2024
Q1 | $45.3K | Buy |
7,334
+2,451
| +50% | +$12.3K | ﹤0.01% | 2199 |
|
|
2023
Q4 | $24.7K | Hold |
4,883
| – | – | ﹤0.01% | 2494 |
|
|
2023
Q3 | $28.1K | Hold |
4,883
| – | – | ﹤0.01% | 2385 |
|
|
2023
Q2 | $17.8K | Buy |
+4,883
| New | +$19.7K | ﹤0.01% | 2622 |
|
|
2022
Q2 | – | Sell |
-2,106
| Closed | -$4K | – | 3252 |
|
|
2022
Q1 | $4K | Hold |
2,106
| – | – | ﹤0.01% | 3011 |
|
|
2021
Q4 | $7K | Hold |
2,106
| – | – | ﹤0.01% | 2996 |
|
|
2021
Q3 | $10K | Hold |
2,106
| – | – | ﹤0.01% | 2946 |
|
|
2021
Q2 | $14K | Hold |
2,106
| – | – | ﹤0.01% | 2875 |
|
|
2021
Q1 | $12K | Hold |
2,106
| – | – | ﹤0.01% | 2789 |
|
|
2020
Q4 | $17K | Hold |
2,106
| – | – | ﹤0.01% | 2563 |
|
|
2020
Q3 | $18K | Buy |
2,106
+440
| +26% | +$4.82K | ﹤0.01% | 2441 |
|
|
2020
Q2 | $17K | Hold |
1,666
| – | – | ﹤0.01% | 2441 |
|
|
2020
Q1 | $16K | Hold |
1,666
| – | – | ﹤0.01% | 2309 |
|
|
2019
Q4 | $13K | Hold |
1,666
| – | – | ﹤0.01% | 2639 |
|
|
2019
Q3 | $34K | Hold |
1,666
| – | – | ﹤0.01% | 2109 |
|
|
2019
Q2 | $43K | Hold |
1,666
| – | – | ﹤0.01% | 2005 |
|
|
2019
Q1 | $65K | Buy |
1,666
+196
| +13% | +$7.95K | ﹤0.01% | 1732 |
|
|
2018
Q4 | $62K | Hold |
1,470
| – | – | ﹤0.01% | 1684 |
|
|
2018
Q3 | $74K | Hold |
1,470
| – | – | ﹤0.01% | 1748 |
|
|
2018
Q2 | $56K | Buy |
1,470
+427
| +41% | +$18.4K | ﹤0.01% | 1919 |
|
|
2018
Q1 | $42K | Hold |
1,043
| – | – | ﹤0.01% | 2012 |
|
|
2017
Q4 | $37K | Hold |
1,043
| – | – | ﹤0.01% | 2098 |
|
|
2017
Q3 | $24K | Hold |
1,043
| – | – | ﹤0.01% | 2337 |
|
|
2017
Q2 | $19K | Buy |
1,043
+467
| +81% | +$10.1K | ﹤0.01% | 2495 |
|
|
2017
Q1 | $16K | Buy |
+576
| New | +$16.1K | ﹤0.01% | 2529 |
|
Other funds holding WVE
GP
6CM
Ameritas Investment Partners's WVE Position: Q2 2026 in Review
Ameritas Investment Partners held its Wave Life Sciences (WVE) position steady in Q2 2026 at 11,436 shares worth $66.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2074.
Ameritas Investment Partners first reported a position in WVE in Q1 2017 and has held it in 34 quarters since. The position peaked at $159K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.
- Ameritas Investment Partners held 11,436 shares of Wave Life Sciences worth $66.4K as of Q2 2026.
- Ameritas Investment Partners left its Wave Life Sciences share count unchanged in Q2 2026.
- Wave Life Sciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2074 holding.
- Ameritas Investment Partners first reported a position in Wave Life Sciences in Q1 2017 and has held it in 34 quarters since.
- Ameritas Investment Partners's Wave Life Sciences position peaked at $159K in Q4 2025.
- 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.